If you invested in in
A $1,000 investment in Charles River Laboratories (CRL) in January 2016 would be worth $2,533 as of June 2026 with dividends reinvested — 9.4% a year. Use the dropdowns above to try any amount, ticker, or starting month back to June 2000.
Growth of $1,000 in CRL since January 2016
dividends reinvested · monthlyCharles River Laboratories (CRL). Total return approximated via dividend- and split-adjusted closes (dividends reinvested, no taxes or fees). Not investment advice.
$1,000 invested in CRL, by starting year
| Invested in | Worth today (div. reinvested) | Price-only | Multiple | Annualized |
|---|---|---|---|---|
| 2000 | $8,476 | $8,476 | 8.5× | 8.6% |
| 2001 | $6,669 | $6,669 | 6.7× | 7.8% |
| 2002 | $6,156 | $6,156 | 6.2× | 7.7% |
| 2003 | $6,315 | $6,315 | 6.3× | 8.2% |
| 2004 | $4,684 | $4,684 | 4.7× | 7.1% |
| 2005 | $3,969 | $3,969 | 4.0× | 6.7% |
| 2006 | $4,077 | $4,077 | 4.1× | 7.1% |
| 2007 | $4,179 | $4,179 | 4.2× | 7.7% |
| 2008 | $3,019 | $3,019 | 3.0× | 6.2% |
| 2009 | $7,704 | $7,704 | 7.7× | 12.5% |
| 2010 | $5,175 | $5,175 | 5.2× | 10.6% |
| 2011 | $4,904 | $4,904 | 4.9× | 10.9% |
| 2012 | $5,569 | $5,569 | 5.6× | 12.7% |
| 2013 | $4,551 | $4,551 | 4.6× | 12.0% |
| 2014 | $3,327 | $3,327 | 3.3× | 10.2% |
| 2015 | $2,712 | $2,712 | 2.7× | 9.2% |
| 2016 | $2,533 | $2,533 | 2.5× | 9.4% |
| 2017 | $2,327 | $2,327 | 2.3× | 9.4% |
| 2018 | $1,784 | $1,784 | 1.8× | 7.2% |
| 2019 | $1,527 | $1,527 | 1.5× | 5.9% |
| 2020 | $1,217 | $1,217 | 1.2× | 3.1% |
| 2021 | $726 | $726 | 0.7× | -5.8% |
| 2022 | $570 | $570 | 0.6× | -12.1% |
| 2023 | $773 | $773 | 0.8× | -7.4% |
| 2024 | $870 | $870 | 0.9× | -5.8% |
| 2025 | $1,141 | $1,141 | 1.1× | 10.2% |
Methodology
Investments are assumed made at the first trading day's close of the chosen year. "Dividends reinvested" uses split- and dividend-adjusted closes (a standard total-return approximation; taxes and fees excluded). "Price-only" uses split-adjusted closes. CRL data begins June 2000; values as of June 2026 and refresh daily. Past performance does not predict future returns; not investment advice.
See the live CRL chart and fundamentals on the CRL quote page or compare with the same investment in SPY.